BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22475888)

  • 1. An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants.
    Youssef NA; Marx CE; Bradford DW; Zinn S; Hertzberg MA; Kilts JD; Naylor JC; Butterfield MI; Strauss JL
    Int Clin Psychopharmacol; 2012 Jul; 27(4):191-6. PubMed ID: 22475888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial.
    Villarreal G; Calais LA; Cañive JM; Lundy SL; Pickard J; Toney G
    Psychopharmacol Bull; 2007; 40(2):6-18. PubMed ID: 17514183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label assessment of aripiprazole in the treatment of PTSD.
    Robert S; Hamner MB; Durkalski VL; Brown MW; Ulmer HG
    Psychopharmacol Bull; 2009; 42(1):69-80. PubMed ID: 19204652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment.
    Naylor JC; Kilts JD; Bradford DW; Strauss JL; Capehart BP; Szabo ST; Smith KD; Dunn CE; Conner KM; Davidson JR; Wagner HR; Hamer RM; Marx CE
    Int Clin Psychopharmacol; 2015 May; 30(3):167-74. PubMed ID: 25647451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression.
    Dunn RT; Stan VA; Chriki LS; Filkowski MM; Ghaemi SN
    J Affect Disord; 2008 Sep; 110(1-2):70-4. PubMed ID: 18272230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia.
    Kim SW; Shin IS; Kim JM; Bae KY; Yang SJ; Yoon JS
    Clin Neuropharmacol; 2010 May; 33(3):121-5. PubMed ID: 20502130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.
    Mischoulon D; Witte J; Levy M; Papakostas GI; Pet LR; Hsieh WH; Pencina MJ; Ward S; Pollack MH; Fava M
    J Clin Psychiatry; 2012 Mar; 73(3):353-7. PubMed ID: 21939613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baclofen treatment for chronic posttraumatic stress disorder.
    Drake RG; Davis LL; Cates ME; Jewell ME; Ambrose SM; Lowe JS
    Ann Pharmacother; 2003 Sep; 37(9):1177-81. PubMed ID: 12921495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness and safety of adjunctive aripiprazole in Taiwanese patients with antidepressant-refractory major depressive disorder: a prospective, open-label trial.
    Chen SJ; Hsiao YL; Shen TW; Chen ST
    J Clin Psychopharmacol; 2012 Feb; 32(1):56-60. PubMed ID: 22198444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
    McElroy SL; Suppes T; Frye MA; Altshuler LL; Stanford K; Martens B; Leverich GS; Post RM; Keck PE
    J Affect Disord; 2007 Aug; 101(1-3):275-81. PubMed ID: 17229469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole augmentation in the treatment of military-related PTSD with major depression: a retrospective chart review.
    Richardson JD; Fikretoglu D; Liu A; McIntosh D
    BMC Psychiatry; 2011 May; 11():86. PubMed ID: 21586149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.
    Glick ID; Mankoski R; Eudicone JM; Marcus RN; Tran QV; Assunção-Talbott S
    J Affect Disord; 2009 May; 115(1-2):18-26. PubMed ID: 19230981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
    Friedman JH; Berman RM; Goetz CG; Factor SA; Ondo WG; Wojcieszek J; Carson WH; Marcus RN
    Mov Disord; 2006 Dec; 21(12):2078-81. PubMed ID: 17013906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole in the management of post-traumatic stress disorder symptoms in returning Global War on Terrorism veterans.
    Lambert MT
    Int Clin Psychopharmacol; 2006 May; 21(3):185-7. PubMed ID: 16528142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans.
    Davis LL; Ward C; Rasmusson A; Newell JM; Frazier E; Southwick SM
    Psychopharmacol Bull; 2008; 41(1):8-18. PubMed ID: 18362867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole in children and adolescents with conduct disorder: a single-center, open-label study.
    Ercan ES; Uysal T; Ercan E; Akyol Ardic U
    Pharmacopsychiatry; 2012 Jan; 45(1):13-9. PubMed ID: 21993869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.
    Kwon JS; Jang JH; Kang DH; Yoo SY; Kim YK; Cho SJ;
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):73-81. PubMed ID: 19154213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot study.
    Pae CU; Marks DM; Han C; Masand PS; Patkar AA
    Int Clin Psychopharmacol; 2009 Jan; 24(1):29-33. PubMed ID: 19060720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
    Tramontina S; Zeni CP; Ketzer CR; Pheula GF; Narvaez J; Rohde LA
    J Clin Psychiatry; 2009 Apr; 70(5):756-64. PubMed ID: 19389329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.